| |
BMC Bioinformatics, Vol. 7 (2006)
|
| |
Western Folklore, Vol. 50, No. 1. (1991), pp. 53-63.
|
| |
Camb. J. Econ., Vol. 19, No. 4. (1 August 1995), pp. 569-590.
|
| |
Asia Pacific Journal of Management
|
| |
Journal of Urban History, Vol. 30, No. 1. (1 November 2003), pp. 21-36.
|
| |
The Journal of Marketing, Vol. 61, No. 4. (1997), pp. 30-54.
|
| |
Econometric Reviews, Vol. 26, No. 2. (2007), pp. 253-288.
|
| |
The Engineering Economist, Vol. 39, No. 2. (1994), pp. 113-138.
|
| |
The Journal of Financial and Quantitative Analysis, Vol. 28, No. 3. (1993), pp. 363-379.
|
| |
Ind Corp Change, Vol. 17, No. 3. (1 June 2008), pp. 467-484.
|
| |
Antipode, Vol. 39, No. 4. (September 2007), pp. 627-648.
|
| |
|
| |
Software, IEEE, Vol. 23, No. 2. (2006), pp. 22-30.
|
| |
The Lancet, Vol. 368, No. 9548., pp. 1660-1672.
|
| |
The Lancet, Vol. 369, No. 9555., pp. 71-77.
|
| |
The American Journal of Medicine In Modifying Cardiovascular and Metabolic Risk Factors: The Role of the Endocannabinoid System and Cannabinoid Receptors, Modifying Cardiovascular and Metabolic Risk Factors: The Role of the Endocannabinoid System and Cannabinoid Receptors, Vol. 120, No. 3, Supplement 1. (March 2007), pp. S26-S34.
|
| |
The American Journal of Medicine In Modifying Cardiovascular and Metabolic Risk Factors: The Role of the Endocannabinoid System and Cannabinoid Receptors, Modifying Cardiovascular and Metabolic Risk Factors: The Role of the Endocannabinoid System and Cannabinoid Receptors, Vol. 120, No. 3, Supplement 1. (March 2007), pp. S19-S25.
|
| |
The Lancet, Vol. 369, No. 9561., 553.
|
| |
The Lancet, Vol. 369, No. 9561., pp. 553-554.
|
| |
The Lancet, Vol. 369, No. 9561., 553.
|
| |
The Lancet, Vol. 369, No. 9561., 555.
|